MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.010
0.00 (0.00%)
Apr 29, 2026, 9:55 AM EDT - Market open
MIRA Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 8.77 | 4.71 | 6.95 | 4.7 | 1.47 | |
| Research & Development | 1.72 | 3.31 | 1.57 | 2.35 | 0.68 | |
| Operating Expenses | 10.49 | 8.02 | 8.53 | 7.05 | 2.15 | |
| Operating Income | -10.49 | -8.02 | -8.53 | -7.05 | -2.15 | |
| Interest Expense | - | - | -3.46 | -0.01 | -0.02 | |
| Interest & Investment Income | 0.1 | 0.17 | - | - | - | |
| Other Non Operating Income (Expenses) | -0.01 | - | - | - | - | |
| EBT Excluding Unusual Items | -10.41 | -7.85 | -11.98 | -7.06 | -2.18 | |
| Gain (Loss) on Sale of Investments | -0.04 | - | - | - | - | |
| Pretax Income | -10.44 | -7.85 | -11.98 | -7.06 | -2.18 | |
| Net Income | -10.44 | -7.85 | -11.98 | -7.06 | -2.18 | |
| Preferred Dividends & Other Adjustments | 21.56 | - | - | - | - | |
| Net Income to Common | -32 | -7.85 | -11.98 | -7.06 | -2.18 | |
| Shares Outstanding (Basic) | 24 | 15 | 14 | 18 | 13 | |
| Shares Outstanding (Diluted) | 24 | 15 | 14 | 18 | 13 | |
| Shares Change (YoY) | 53.42% | 10.91% | -20.73% | 38.60% | - | |
| EPS (Basic) | -1.35 | -0.51 | -0.86 | -0.40 | -0.17 | |
| EPS (Diluted) | -1.35 | -0.51 | -0.86 | -0.40 | -0.17 | |
| EBIT | -10.49 | -8.02 | -8.53 | -7.05 | -2.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.